| 產品名稱 | BT-11 |
| 產品貨號 | Axon 2749 CAS [1912399-75-7] MF C30H24N8O2MW 528.56 Purity: 99% Soluble in DMSO Description BT-11 is a first-in-class, orally active lanthionine synthetase C-like 2 (LANCL2) binding compound (Kd value of 7.7 μM) for treating inflammatory bowel disease (IBD). Moreover, BT-11 downregulates expression of pro-inflammatory cytokines (e.g., TNF-α or interferon-γ, which are hallmarks of IBD), and promotes IL-10-mediated anti-inflammatory responses in the GI tract. KEYWORDS: BT-11 | supplier | LANCL2 modulator | BT11 | BT 11 | CAS [1912399-75-7] | Abscisic acid | LANCL | Modulator | Receptors | IBD |
| 產品價格 | 現貨詢價，電話：010-67529703 |
| 產品規格 | |
| 產品品牌 | axonmedchem |
| 產品概述 | |
| 產品詳情 |
BT-11Axon 2749 CAS [1912399-75-7] MF C30H24N8O2
DescriptionBT-11 is a first-in-class, orally active lanthionine synthetase C-like 2 (LANCL2) binding compound (Kd value of 7.7 μM) for treating inflammatory bowel disease (IBD). Moreover, BT-11 downregulates expression of pro-inflammatory cytokines (e.g., TNF-α or interferon-γ, which are hallmarks of IBD), and promotes IL-10-mediated anti-inflammatory responses in the GI tract. KEYWORDS: BT-11 | supplier | LANCL2 modulator | BT11 | BT 11 | CAS [1912399-75-7] | Abscisic acid | LANCL | Modulator | Receptors | IBD
First-in-class, orally active LANCL2 binding compound
Chemical namePiperazine-1,4-diylbis((6-(1H-benzo[d]imidazol-2-yl)pyridin-2-yl)methanone) Parent CAS No.[1912399-75-7] |
| 產品資料 |
